Johnson & Johnson (JNJ)
207.63
-0.15
(-0.07%)
USD |
NYSE |
Dec 26, 16:00
208.23
+0.60
(+0.29%)
Pre-Market: 07:29
Johnson & Johnson Shareholders Equity (Quarterly): 79.28B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Gilead Sciences, Inc. | 21.54B |
| Eli Lilly & Co. | 23.79B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Protagonist Therapeutics, Inc. | 645.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.82B |
| Total Liabilities (Quarterly) | 113.54B |
| Debt to Equity Ratio | 0.5777 |
| Current Ratio | 1.074 |
| Net Debt Paydown Yield | -0.19% |